2022
DOI: 10.2174/1573406417666210604103135
|View full text |Cite
|
Sign up to set email alerts
|

Utility of Certain 2-Furanone Derivatives for Synthesis of Different Heterocyclic Compounds and Testing their Anti-Cancer Activity

Abstract: Background: 2-Furanones attracted great attention due to their biological activities. They also have the ability to convert to several biologically active heterocyclic and non-heterocyclic compounds, especially as anti-cancer agents. Objectives: This research aims to assist in the development process of novel cytotoxic agents through synthesizing certain 2-furanone derivatives, using them as starting materials for the preparation of novel heterocyclic and non-heterocyclic compounds, and then testing the syn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 36 publications
1
0
0
Order By: Relevance
“…The study recommended the downregulation of both MAPK14 and P-MAPK14 by downregulating CDC25B as a possible method to suppress the proliferation and migration of ccRCC [ 40 ]. By downregulating MAPK14 in renal cancer cells lines using a 2-Furanone compound called “compound 3a”, Abd El-Hameed et al [ 41 ] showed that these have promising anticancer activities and corroborrate our suggestion that MAPK14 could be a very promising target against kidney cancer.…”
Section: Discussionsupporting
confidence: 71%
“…The study recommended the downregulation of both MAPK14 and P-MAPK14 by downregulating CDC25B as a possible method to suppress the proliferation and migration of ccRCC [ 40 ]. By downregulating MAPK14 in renal cancer cells lines using a 2-Furanone compound called “compound 3a”, Abd El-Hameed et al [ 41 ] showed that these have promising anticancer activities and corroborrate our suggestion that MAPK14 could be a very promising target against kidney cancer.…”
Section: Discussionsupporting
confidence: 71%